Thursday, March 31, 2011

David Livermore fights NDM-1, the 'super' superbug

David Livermore and NDM-1
There is a new story at MSNBC.com highlighting David Livermore, NDM-1, and the myriad of reasons for the expansion of MDR-bacteria and hospital infections: little investment in antibiotic discovery and infection prevention.  I like this quote from the article in regards to infection prevention: "If it is done properly, it can ease the demand for drugs in the first place."  Dr. Livermore is the Director of the Antibiotic Resistance Monitoring & Reference Laboratory (ARMRL) at the HPA Centre for Infections in London. The story is surprisingly well-written, includes the usual human-interest angle and quite long but worth a read.

h/t Mark Vander Weg

1 comment:

  1. You guys might want to talk a look at a piece I did for Scientific American this month, on carbapenem resistance. Unfortunately only the preview is available on the web (frown), but it is 4k words long and pretty detailed.
    http://www.scientificamerican.com/article.cfm?id=the-enemy-within

    ReplyDelete